InsiderTrades

Form 4 for COCH Envoy Medical, Inc.

Accepted 2023-10-03 00:00:00 ET · period of report 2023-09-29 · accession 0001062993-23-018934 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-10-03 2023-09-29 COCH Hirsch Daniel J. CFO, Corp. Sec, Dir C - Cnv Deriv $0.00 +25.0K 25.0K New $0
D 2023-10-03 2023-09-29 COCH Hirsch Daniel J. CFO, Corp. Sec, Dir C - Cnv Deriv $0.00 -25.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock, par value $0.0001 per share 2023-09-29 C A 25,000 $0.00 25,000 D — — (F1) On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu.
2 Derivative Class B Common Stock, par value $0.0001 per share 2023-09-29 C D 25,000 $0.00 0 D — · — to — 25,000 Class A Common Stock, par value $0.0001 per share (F1) On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu.